top of page
Designing novel therapeutics by looking through a PRISM™
A Revolutionary Approach to Novel Drug Design
The PRISM™ platform employes a novel set of proprietary algorithms and advanced simulation programs to determine targetability and disease relevance, de novo compound design, chemistry optimization, and predict drug-like properties... all before a single synthetic reaction takes place.
De novo Chemistry and Specific Compound Design No Therapeutics Barriers, Disruptive Potential
No Compound Screening Translates to
an Accelerated Approach to Drug Discovery
The PRISM™ Advantage
Custom designed target specific compounds
ADME & PK optimized for translation to clinic
Ensured synthetic feasibility for CMC readiness
Unparelled speed to development candidate
Robust cost effectivness & reduced risk
© Copyright 2023 Asha Therapeutics, all rights reserved
Website designed & maintained by A3 Media
bottom of page